BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30509347)

  • 1. [Premenstrual dysphoric disorder is often overlooked].
    Reveles Jensen KH; Sinclair K
    Ugeskr Laeger; 2018 Nov; 180(47):. PubMed ID: 30509347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Generalized Anxiety Disorder and Premenstrual Dysphoric Disorder in a Diagnostic Interviewing Study.
    Yen JY; Lin PC; Huang MF; Chou WP; Long CY; Ko CH
    Int J Environ Res Public Health; 2020 Feb; 17(3):. PubMed ID: 32033286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of premenstrual dysphoric disorder.
    Rapkin AJ; Lewis EI
    Womens Health (Lond); 2013 Nov; 9(6):537-56. PubMed ID: 24161307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.
    Dunphy L; Boyle S; Wood F
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38160030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder.
    Sundström-Poromaa I; Comasco E
    CNS Drugs; 2023 May; 37(5):371-379. PubMed ID: 37171547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.
    Luisi AF; Pawasauskas JE
    Pharmacotherapy; 2003 Sep; 23(9):1131-40. PubMed ID: 14524645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premenstrual Syndrome and Premenstrual Dysphoric Disorder.
    Hofmeister S; Bodden S
    Am Fam Physician; 2016 Aug; 94(3):236-40. PubMed ID: 27479626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Premenstrual syndrome and premenstrual dysphoric disorder].
    Kovács Z; Hegyi G; Szőke H
    Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily symptom ratings for studying premenstrual dysphoric disorder: A review.
    Bosman RC; Jung SE; Miloserdov K; Schoevers RA; aan het Rot M
    J Affect Disord; 2016 Jan; 189():43-53. PubMed ID: 26406968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of premenstrual symptom severity and impairment in Korean adolescents: premenstrual dysphoric disorder, subthreshold premenstrual dysphoric disorder and premenstrual syndrome.
    Yang J; Joe SH; Lee MS; Kim SH; Jung IK
    Asia Pac Psychiatry; 2014 Jun; 6(2):135-44. PubMed ID: 23857722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does premenstrual dysphoric disorder relate to depression and anxiety disorders?
    Landén M; Eriksson E
    Depress Anxiety; 2003; 17(3):122-9. PubMed ID: 12768646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests.
    Inoue Y; Terao T; Iwata N; Okamoto K; Kojima H; Okamoto T; Yoshimura R; Nakamura J
    Psychopharmacology (Berl); 2007 Feb; 190(2):213-9. PubMed ID: 17072588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premenstrual Dysphoric Disorder.
    Lanza di Scalea T; Pearlstein T
    Med Clin North Am; 2019 Jul; 103(4):613-628. PubMed ID: 31078196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premenstrual disorders.
    Yonkers KA; Simoni MK
    Am J Obstet Gynecol; 2018 Jan; 218(1):68-74. PubMed ID: 28571724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention, response inhibition, impulsivity, and decision-making within luteal phase in women with premenstrual dysphoric disorder.
    Yen JY; Lin PC; Hsu CJ; Lin C; Chen IJ; Ko CH
    Arch Womens Ment Health; 2023 Jun; 26(3):321-330. PubMed ID: 37010619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
    Beddig T; Reinhard I; Kuehner C
    Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
    Halbreich U; Smoller JW
    J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.